Assessing the Future of Robotics in Medtech

Posted by Andy Kach on August 14, 2019

This article was originally published in Medtech Insight.

Every medical device company—in and out of the surgical business—and many other tech companies are deep in the war of surgical robotics and digital solutions.


>
Read More

AI in Medtech: Innovating in An Era of Uncertainty

Posted by Kate Templeton on July 23, 2019

This post is the second in a multi-part series on how the rules of the road are changing in medtech, and the implications on commercial strategy. Sundeep Karnik contributed to this blog post.

With the speed and impact of innovation increasing rapidly, our institutions have struggled to keep up. For better or worse, rules and regulations have typically lagged behind the innovation frontier, responding only when a crisis or particular incident highlights a new challenge to be managed or risk to be mitigated. This dynamic isn’t specific to healthcare—just think back on all of the questions raised in the last few years with Tesla’s autopilot car crashes to see the parallels. Regardless of industry, for those innovators on the cutting edge, this creates an environment of regulatory uncertainly that is inherently risky for the companies that blaze forward assuming a specific regulatory approach will be adopted by the relevant authorities. The more disruptive the technology, the more likely it is that such an environment will exist.


>
Read More

Analytics Is Not Rocket Science, but it’s Certainly More Than Reports

Posted by Maria Kliatchko on September 17, 2018

Today, when we think of advanced analytics, we think of AI solutions like self-driving cars, automated personal assistants or cancer diagnoses by image recognition. But when many medtech leaders go to work, all they see is reports. For commercial leaders and field managers, “analytics” is limited to slicing and dicing some data, at times with better visualizations and dashboards. Medtech needs to up its analytics game, but what does that entail?


>
Read More

Musings From the ADA: Medtech Needs to Balance Health and Happiness in Diabetes

Posted by Andy Kach on June 15, 2017

I just came back from my first American Diabetes Association Scientific Sessions event, held June 9-13 in San Diego, and there were a number of surprising revelations about the medical device industry’s role in diabetes treatment. 


>
Read More